Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 6, 2012
MADIT-RIT clinical trial study results published today in the New England Journal of Medicine
-
Nov 1, 2012
Appointment completes company's CEO transition plan; Mahoney Replaces Interim CEO William H. (Hank) Kucheman.
-
Oct 31, 2012
Innovative bioabsorbable coating is the first to complete absorption shortly after drug elution ends at three months.
-
Oct 24, 2012
Language update supports the strong safety profile for PROMUS Element and PROMUS Element Plus Stents.
-
Oct 23, 2012
PLATINUM Long Lesion clinical results presented at TCT 2012 show no heart attack or stent thrombosis at two-year follow-up.
-
Oct 23, 2012
Twelve-month data presented at TCT 2012 support safety and efficacy of Epic stent in iliac stenting.
-
Oct 23, 2012
Results presented on cost effectiveness and clinical benefits for older patients of the WATCHMAN® Left Atrial Appendage Closure Device; Lotus™ Aortic Valve System feasibility trial results reviewed.
-
Oct 18, 2012
Clinical presentations will provide new insights on Boston Scientific research in coronary and peripheral artery disease, including aortic valve disease and atrial fibrillation.
-
Oct 18, 2012
"We remain focused on executing our strategy to drive this organization back to revenue growth,” said CEO Hank Kucheman.
-
Oct 10, 2012
REPRISE II study results expected to support CE Mark and other regulatory filings.